Brawn Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	60	63	49	60	50	52
Market Cap Growth	10.04%	28.31%	-18.75%	20.85%	-4.61%	-21.49%
Enterprise Value	57	61	46	56	47	48
Last Close Price	19.95	20.85	16.25	20.00	16.55	17.35
PE Ratio	6.12	6.65	-	-	-	-
PS Ratio	0.35	0.37	0.36	0.36	0.22	0.60
PB Ratio	1.38	1.44	1.45	1.19	0.79	0.72
P/TBV Ratio	1.38	1.44	1.45	1.19	0.79	0.72
P/FCF Ratio	69.91	73.06	-	-	22.33	-
P/OCF Ratio	53.51	55.93	102.80	-	15.62	27.72
EV/Sales Ratio	0.34	0.36	0.34	0.34	0.21	0.56
EV/FCF Ratio	66.63	70.85	-	-	21.32	-
Net Debt / Equity Ratio	-0.06	-0.06	-0.06	-0.08	-0.07	-0.03
Net Debt / EBITDA Ratio	0.86	0.86	0.11	0.26	1.48	0.11
Net Debt / FCF Ratio	-3.28	-3.28	1.03	10.54	-1.97	2.06
Asset Turnover	0.82	0.82	0.77	1.13	1.57	0.62
Inventory Turnover	1.42	1.42	1.47	2.69	4.06	2.77
Quick Ratio	0.25	0.25	0.39	0.67	0.73	0.63
Current Ratio	1.13	1.13	1.88	2.02	1.67	1.93
Return on Equity (ROE)	24.43%	24.43%	-41.30%	-21.93%	-12.83%	-20.54%
Return on Assets (ROA)	-1.36%	-1.36%	-6.69%	-6.71%	-1.79%	-9.30%
Return on Invested Capital (ROIC)	-11.84%	-12.42%	-47.91%	-29.67%	-6.30%	-26.72%
Return on Capital Employed (ROCE)	-7.90%	-7.90%	-16.80%	-19.30%	-6.30%	-27.60%
Earnings Yield	15.71%	15.04%	-35.69%	-20.78%	-17.48%	-31.59%
FCF Yield	1.43%	1.37%	-3.98%	-0.63%	4.48%	-2.10%
Buyback Yield / Dilution	3.83%	3.83%	-	-	-	-
Total Shareholder Return	3.83%	3.83%	-	-	-	-